AI4Health PhDs at MICCAI
AI for Healthcare CDT Researchers had paper accepted by major AI conference
Several papers accepted by MICCAI 2022 by PhD students from the AI for Healthcare CDT
AI for Healthcare CDT Researchers had paper accepted by major AI conference
Several papers accepted by MICCAI 2022 by PhD students from the AI for Healthcare CDT
Arm-strengthening device to be brought to the clinic with £800k grant
Imperial and GripAble have been awarded an £800k grant to help children with cerebral palsy in the clinic using a new arm-strengthening device.
Parasite-detecting DNA biosensors offer new tool to tackle schistosomiasis
Researchers have developed new DNA biosensors capable of rapidly detecting and differentiating between parasites that cause schistosomiasis.
£1.5M award for new network to address brain disorders
An Imperial-led team has won £1.5M to establish a research network in neuromodulation.
Why are heart attack deaths 160% higher in some areas of England than others?
A new study has found the variation in hospital fatality rates is only a small contributor to geographical variation in heart attack deaths in England
£1.6 million raised for Parkinson’s Disease continuous monitoring technology
Imperial startup SERG Technologies has raised funds to further develop its technology to monitor and optimise treatment of Parkinson's.
Infectious disease trailblazers inspire Great Exhibition Road Festival-goers
No stranger to trailblazers, the Department of Infectious Disease had a strong presence at the 2022 Great Exhibition Road Festival.
New data synthesis tool can rapidly sort complex datasets to aid decision-makers
A new data synthesis tool can help tackle ‘infodemics’ by quickly sorting through large, complex datasets to make optimal decisions for society.
Children and young people’s mental health needs rising threefold
A new report examines the impact of COVID-19 on the mental health of children and young people in North West London.
New leadership at Imperial Clinical Trials Unit
Dr Victoria Cornelius has been appointed as the Director of Imperial Clinical Trials Unit (ICTU).